₹1,122.7
▲ +23.52 +2.14%
As of 29 Jul 2026 · delayed
NSE Listed · Pharmaceuticals
Zydus Lifesciences Ltd. (ZYDUSLIFE)
Volume: 10,97,337Avg Vol 1W: 8,39,382Avg Vol 1M: 12,39,76252W Range:₹835.5₹1,181.5
Key Ratios
Checked just nowMarket Cap₹1,11,990 Cr
Current Price₹1,122.7
Previous Close₹1,099.18
High / Low (52w)₹1,181.5 / ₹835.5
Volume10,97,337
Avg Vol (1W)8,39,382
Avg Vol (1M)12,39,762
Stock P/E88.75
Book Value₹271.78
Dividend Yield9%
ROE18.59%
ROA9.59%
Revenue (TTM)—
Revenue Growth18.9%
Profit Margin18.86%
Total Debt₹0 Cr
Shares Outstanding100 Cr
Face Value₹1
EPS (TTM)₹54.46
P/B4.13
Debt / Equity0.31
50 DMA₹1,103.54
200 DMA₹969.67
Day change+2.14%
Price Chart
₹1,122.7▲ 12.85% · 1Y
2025-07-292026-07-29
20-day avg volume: 12.3L shares
Pros
- Healthy return on equity of 18.6%.
- Pays a dividend yield of 9.0%.
- Company is almost debt-free.
- Revenue grew 639% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 89.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹6,208 Cr | ₹5,237 Cr | ₹5,269 Cr | ₹6,528 Cr | ₹6,574 Cr | ₹6,123 Cr | ₹6,865 Cr | ₹7,587 Cr |
| EBITDA | ₹1,932 Cr | ₹1,296 Cr | ₹1,216 Cr | ₹1,968 Cr | ₹2,005 Cr | ₹1,823 Cr | ₹1,568 Cr | ₹2,180 Cr |
| Net Profit | ₹1,420 Cr | ₹911 Cr | ₹1,024 Cr | ₹1,171 Cr | ₹1,467 Cr | ₹1,259 Cr | ₹1,042 Cr | ₹1,273 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,516 Cr | ₹23,511 Cr | ₹5,820 Cr | ₹2,588 Cr | ₹2,871 Cr | ₹2,284 Cr | ₹27,658 Cr | ₹3,741 Cr |
| EBITDA | ₹594 Cr | ₹6,412 Cr | ₹3,830 Cr | ₹613 Cr | ₹1,557 Cr | ₹529 Cr | ₹7,577 Cr | ₹2,333 Cr |
| Net Profit | ₹471 Cr | ₹4,526 Cr | ₹2,814 Cr | ₹385 Cr | ₹1,157 Cr | ₹297 Cr | ₹5,040 Cr | ₹1,722 Cr |
| EPS | — | 44.97 | — | — | — | — | 50.09 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹23,483 Cr | ₹23,687 Cr | ₹23,885 Cr | ₹27,795 Cr | ₹25,756 Cr | ₹29,281 Cr | ₹37,202 Cr | ₹52,407 Cr |
| Total Liabilities | ₹11,804 Cr | ₹11,976 Cr | ₹8,955 Cr | ₹8,742 Cr | ₹6,068 Cr | ₹7,179 Cr | ₹10,843 Cr | ₹22,824 Cr |
| Equity | ₹11,679 Cr | ₹11,710 Cr | ₹14,930 Cr | ₹19,054 Cr | ₹19,688 Cr | ₹22,102 Cr | ₹26,358 Cr | ₹29,582 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹1,950 Cr | ₹2,808 Cr | ₹3,638 Cr | ₹2,779 Cr | ₹3,281 Cr | ₹4,514 Cr | ₹8,583 Cr | ₹3,708 Cr |
| Investing | ₹-4,239 Cr | ₹-1,012 Cr | ₹-722 Cr | ₹1,154 Cr | ₹1,171 Cr | ₹-1,475 Cr | ₹-8,358 Cr | ₹-8,296 Cr |
| Financing | ₹1,885 Cr | ₹-1,094 Cr | ₹-2,549 Cr | ₹-868 Cr | ₹-4,400 Cr | ₹-1,810 Cr | ₹1,995 Cr | ₹5,807 Cr |
| Free Cash Flow | ₹1,950 Cr | ₹2,808 Cr | ₹3,638 Cr | ₹2,779 Cr | ₹3,281 Cr | ₹4,514 Cr | ₹8,583 Cr | ₹3,708 Cr |
Shareholding
Promoter 75.01% Institutions 18.16% Public 6.83%
Efficiency & Working Capital
ROCE17.4%
Interest Coverage16.1
Dividend Payout—
Debtor Days63 d
Inventory Days62 d
Payable Days36 d
Cash Conversion Cycle89 d
Working Capital Days125 d
Shareholding Details
As of 2026-06-30
Promoter75%
FII6.9%
DII11.3%
Institutions18.2%
Public6.8%
Promoter Pledge0%
No. of Shareholders3,99,251
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 4.9% | 5% | 5.7% | 5.6% | 7.5% | 7.5% | 7.3% | 7.1% | 7.3% | 7.1% | 6.9% | 6.9% |
| DIIs | 13.1% | 12.8% | 12.6% | 12.6% | 10.7% | 10.7% | 11% | 11.1% | 10.9% | 11.1% | 11.2% | 11.3% |
| Public | 7.1% | 7.2% | 6.7% | 6.8% | 6.8% | 6.8% | 6.7% | 6.7% | 6.8% | 6.9% | 6.9% | 6.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,97,953 | 3,06,495 | 2,94,324 | 3,36,309 | 3,70,863 | 3,65,356 | 3,71,619 | 3,86,127 | 3,96,105 | 4,03,266 | 4,18,314 | 3,99,251 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Zydus Family Trust (pankaj R. Patel, Pritiben P. Patel And Sharvil P. Patel-trustees) | Shareholding of Promoter and Promoter Group | 75% | 74.80 Cr |
| Life Insurance Corporation Of India | Public Shareholding | 5.4% | 5.40 Cr |
| Parag Parikh Flexi Cap Fund | Public Shareholding | 2% | 2.02 Cr |
| Kotak Flexicap Fund | Public Shareholding | 1.2% | 1.19 Cr |
| Arati Rajiv Mehta | Shareholding of Promoter and Promoter Group | 0% | 75,447 |
| Ayushi Rajiv Mehta Jointly With Arati Rajiv Mehta | Shareholding of Promoter and Promoter Group | 0% | 17,727 |
| Jasodaben Babubhai Patel | Shareholding of Promoter and Promoter Group | 0% | 32,577 |
| Ritaben Yatinbhai Desai | Shareholding of Promoter and Promoter Group | 0% | 24,665 |
| Gira Vijay Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Prashant Babubhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Meha Sharvil Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shaurya Sharvil Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Veda Sharvil Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kektiben Mukeshbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sharvil P. Patel Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pripan Investment Private Limited | Shareholding of Promoter and Promoter Group | 0% | 17,581 |
| Pankaj Ramanbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 43,969 |
| Pankaj Ramanbhai Patel Huf (pankaj Ramanbhai Patel-karta) | Shareholding of Promoter and Promoter Group | 0% | 29,302 |
| Pritiben Pankajbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 14,651 |
| Sharvil Pankajbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 14,651 |
| Shivani Pankajbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 14,651 |
| Taraben Patel Family Will Trust (mr.pankaj R Patel And Dr. Sharvil P Patel-trustees) | Shareholding of Promoter and Promoter Group | 0% | 14,651 |
| Zydus Hospitals And Healthcare Research Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Cadmach Machinery Company Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Cadila Laboratories Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Pankaj R Patel | Chairman(Non Exe)&Dir(Non-Ind) | 2026 |
| Sharvil P Patel | Executive Director & MD | 2026 |
| Ganesh N Nayak | Executive Director | 2026 |
| Mukesh Patel | Non-Exec & Non-Independent Dir | 2026 |
| Bhadresh K Shah | Independent Non Exe. Director | 2026 |
| Akhil A. Monappa | Independent Non Exe. Director | 2026 |
| Upsana Kamineni | Independent Non Exe. Director | 2026 |
| Shelina P. Parikh | Independent Non Exe. Director | 2026 |
| Kulin S Lalbhai | Independent Director | 2026 |
| Dhaval N Soni | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Healthcare | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹1 | 173 | 101 | 101 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-11 | Board Meetings | — |
| forthcoming | 2026-07-24 | Dividend (1/- per share) | Final |
| dividend | 2026-07-24 | ₹1 (100%) | Final |
| buyback | 2026-06-10 | ₹1260.0 max | — |
| buyback | 2026-06-10 | ₹1260 max | — |
| dividend | 2025-07-25 | ₹11 (1100%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 40,849 | 0 | 135 | 0 | 151 | 41,135 |
| 2026 | 8,892 | 0 | 25 | 0 | 2 | 8,919 |
| 2026 | 22,780 | 0 | 10 | 0 | 72 | 22,862 |
Insider / Designated-Person Trades
32 recent disclosure(s)
Tushar Dhansukh ShroffDisposal · 5
Jigar Mukesh PatelDisposal · 73
Mukesh Mangalbhai PatelDisposal · 98
Ritaben Yatin DesaiDisposal · 209
Arati Rajiv Mehta Joint with Rajiv Vastupal MehtaDisposal · 640
R B Patel Will Pankaj TrustDisposal · 109
Substantial Acquisitions (SAST)
1 disclosure(s)
Market01/08/2025 · 2,00,000
Company Information
Incorporated1995
ChairmanPankaj R Patel
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]; upen.shah@zyduscadila.
📍 Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad, Gujarat, 382481
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search